vs

Side-by-side financial comparison of APi Group Corp (APG) and Dexcom (DXCM). Click either name above to swap in a different company.

APi Group Corp is the larger business by last-quarter revenue ($2.1B vs $1.3B, roughly 1.7× Dexcom). Dexcom runs the higher net margin — 21.2% vs 4.6%, a 16.6% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 13.8%). Over the past eight quarters, APi Group Corp's revenue compounded faster (15.0% CAGR vs 12.0%).

X.AI Corp., doing business as xAI, is an American company working in the area of artificial intelligence (AI), social media and technology that is a wholly owned subsidiary of American aerospace company SpaceX. Founded by Elon Musk in 2023, the company's flagship products are the generative AI chatbot named Grok and the social media platform X, the latter of which they acquired in March 2025.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

APG vs DXCM — Head-to-Head

Bigger by revenue
APG
APG
1.7× larger
APG
$2.1B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+7.8% gap
DXCM
21.6%
13.8%
APG
Higher net margin
DXCM
DXCM
16.6% more per $
DXCM
21.2%
4.6%
APG
Faster 2-yr revenue CAGR
APG
APG
Annualised
APG
15.0%
12.0%
DXCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
APG
APG
DXCM
DXCM
Revenue
$2.1B
$1.3B
Net Profit
$97.0M
$267.3M
Gross Margin
32.0%
62.9%
Operating Margin
7.7%
25.6%
Net Margin
4.6%
21.2%
Revenue YoY
13.8%
21.6%
Net Profit YoY
44.8%
153.6%
EPS (diluted)
$-1.16
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APG
APG
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$2.1B
$1.3B
Q3 25
$2.1B
$1.2B
Q2 25
$2.0B
$1.2B
Q1 25
$1.7B
$1.0B
Q4 24
$1.9B
$1.1B
Q3 24
$1.8B
$994.2M
Q2 24
$1.7B
$1.0B
Net Profit
APG
APG
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$97.0M
$267.3M
Q3 25
$93.0M
$283.8M
Q2 25
$77.0M
$179.8M
Q1 25
$35.0M
$105.4M
Q4 24
$67.0M
$151.7M
Q3 24
$69.0M
$134.6M
Q2 24
$69.0M
$143.5M
Gross Margin
APG
APG
DXCM
DXCM
Q1 26
62.9%
Q4 25
32.0%
62.9%
Q3 25
31.3%
60.5%
Q2 25
30.9%
59.5%
Q1 25
31.5%
56.9%
Q4 24
30.9%
58.9%
Q3 24
31.1%
59.7%
Q2 24
31.4%
62.4%
Operating Margin
APG
APG
DXCM
DXCM
Q1 26
25.6%
Q4 25
7.7%
25.6%
Q3 25
7.8%
20.1%
Q2 25
7.2%
18.4%
Q1 25
4.9%
12.9%
Q4 24
6.2%
17.0%
Q3 24
7.8%
15.3%
Q2 24
7.3%
15.7%
Net Margin
APG
APG
DXCM
DXCM
Q1 26
21.2%
Q4 25
4.6%
21.2%
Q3 25
4.5%
23.5%
Q2 25
3.9%
15.5%
Q1 25
2.0%
10.2%
Q4 24
3.6%
13.6%
Q3 24
3.8%
13.5%
Q2 24
4.0%
14.3%
EPS (diluted)
APG
APG
DXCM
DXCM
Q1 26
$0.67
Q4 25
$-1.16
$0.67
Q3 25
$0.20
$0.70
Q2 25
$0.16
$0.45
Q1 25
$0.11
$0.27
Q4 24
$0.05
$0.37
Q3 24
$0.23
$0.34
Q2 24
$0.22
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APG
APG
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$912.0M
$917.7M
Total DebtLower is stronger
$2.8B
Stockholders' EquityBook value
$3.4B
$2.7B
Total Assets
$8.9B
$6.3B
Debt / EquityLower = less leverage
0.81×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APG
APG
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$912.0M
$917.7M
Q3 25
$555.0M
$1.8B
Q2 25
$432.0M
$1.2B
Q1 25
$460.0M
$904.9M
Q4 24
$499.0M
$606.1M
Q3 24
$487.0M
$621.2M
Q2 24
$324.0M
$939.2M
Total Debt
APG
APG
DXCM
DXCM
Q1 26
Q4 25
$2.8B
Q3 25
$2.8B
Q2 25
$2.8B
Q1 25
$2.8B
Q4 24
$2.8B
Q3 24
$2.9B
Q2 24
$2.8B
Stockholders' Equity
APG
APG
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$3.4B
$2.7B
Q3 25
$3.3B
$2.7B
Q2 25
$3.2B
$2.6B
Q1 25
$3.0B
$2.3B
Q4 24
$3.0B
$2.1B
Q3 24
$3.0B
$2.0B
Q2 24
$2.8B
$2.4B
Total Assets
APG
APG
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$8.9B
$6.3B
Q3 25
$8.7B
$7.5B
Q2 25
$8.5B
$7.3B
Q1 25
$8.1B
$6.8B
Q4 24
$8.2B
$6.5B
Q3 24
$8.2B
$6.4B
Q2 24
$8.0B
$6.8B
Debt / Equity
APG
APG
DXCM
DXCM
Q1 26
Q4 25
0.81×
Q3 25
0.84×
Q2 25
0.87×
Q1 25
0.92×
Q4 24
0.93×
Q3 24
0.96×
Q2 24
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APG
APG
DXCM
DXCM
Operating Cash FlowLast quarter
$382.0M
Free Cash FlowOCF − Capex
$356.0M
FCF MarginFCF / Revenue
16.8%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
3.94×
TTM Free Cash FlowTrailing 4 quarters
$663.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APG
APG
DXCM
DXCM
Q1 26
Q4 25
$382.0M
$294.0M
Q3 25
$232.0M
$659.9M
Q2 25
$83.0M
$303.0M
Q1 25
$62.0M
$183.8M
Q4 24
$283.0M
$301.4M
Q3 24
$220.0M
$199.5M
Q2 24
$110.0M
$279.4M
Free Cash Flow
APG
APG
DXCM
DXCM
Q1 26
Q4 25
$356.0M
$192.1M
Q3 25
$201.0M
$579.4M
Q2 25
$56.0M
$208.9M
Q1 25
$50.0M
$96.8M
Q4 24
$265.0M
$176.8M
Q3 24
$198.0M
$88.3M
Q2 24
$88.0M
$213.3M
FCF Margin
APG
APG
DXCM
DXCM
Q1 26
Q4 25
16.8%
15.3%
Q3 25
9.6%
47.9%
Q2 25
2.8%
18.1%
Q1 25
2.9%
9.3%
Q4 24
14.2%
15.9%
Q3 24
10.8%
8.9%
Q2 24
5.1%
21.2%
Capex Intensity
APG
APG
DXCM
DXCM
Q1 26
Q4 25
1.2%
8.1%
Q3 25
1.5%
6.7%
Q2 25
1.4%
8.1%
Q1 25
0.7%
8.4%
Q4 24
1.0%
11.2%
Q3 24
1.2%
11.2%
Q2 24
1.3%
6.6%
Cash Conversion
APG
APG
DXCM
DXCM
Q1 26
Q4 25
3.94×
1.10×
Q3 25
2.49×
2.33×
Q2 25
1.08×
1.69×
Q1 25
1.77×
1.74×
Q4 24
4.22×
1.99×
Q3 24
3.19×
1.48×
Q2 24
1.59×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons